Variable biological effectiveness of proton beams

66

No. 187 in all physics · No. 6 in Medical and Radiation Physics

Non-expert version

Determine the proton relative biological effectiveness as a function of dose-averaged linear energy transfer $\mathrm{LET}_{d}$ from $1 \text{ to } 15\,\mathrm{keV}/\mathrm{micron}$, dose per fraction from $100 \text{ to } 1000\,\mathrm{rad}$, and tissue $\alpha/\beta$ from $200 \text{ to } 1000\,\mathrm{rad}$, for clinically relevant normal-tissue endpoints. The clinical standard $\mathrm{RBE} = 1.1$ is constant. An answer is a validated RBE model with uncertainty bands usable in treatment planning.

What would settle it

Clinical outcome data correlating observed normal-tissue changes with planned $\mathrm{LET}_{d}$ distributions, combined with in vivo endpoint measurements along a spread-out Bragg peak.

Status in the literature

Unverified note: it names recent work and was partly written without a live literature search; it awaits a check by an editor.

Imaging-based evidence of elevated effect at the distal edge in brain accumulated through 2024, but no variable-RBE model had been clinically adopted.

Subproblems (1)

How results are checked

See also

Comments (0)

Comments are not records: they are not signed, stamped or logged. How comments work

No comments yet.

Sign in to comment.

Details, signature and history
Kind
Phenomenon to explain
Answer
Value
Posed
1990
Topic review
Paganetti, Relative biological effectiveness (RBE) values for proton beam therapy: variations as a function of biological endpoint, dose, and linear energy transfer, Physics in Medicine and Biology, 2014. Link
Record
Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor

Proof

Fingerprint
36b43a26a16b…
Public log
Entry 1,692, in checkpoint 2,123
In the log by
Block 969,698, 2026-10-03

This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.

History